Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market to grow with Rising Cases of Chronic Diseases

According to a new market research report launched by Inkwood Research, the Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market is evolving at a CAGR of 20.65% over the forecasting period of 2021 and 2028, and is projected to generate a revenue of $3545.9 million by 2028

Browse 43 market data Tables and 44 figures spread over 147 Pages, along with in-depth analysis on Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market by Type, End-User, & by Geography

Request Free Sample Report for Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market by Type, End-User & by Geography: https://www.inkwoodresearch.com/reports/non-alcoholic-steatohepatitis-biomarker-market/#request-free-sample

This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market, by assessing major geographies, and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain.

Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market Scenario

Non-alcoholic steatohepatitis (NASH) is a non-alcoholic fatty liver disease (NAFLD). It progresses to severe disorders like hepatocellular carcinoma and cirrhosis. NASH is also estimated to become a major cause of liver transplantation in the coming decade. NAFLD is attributed to several metabolic comorbidities like metabolic syndrome, dyslipidemia. According to the Diabetes Research and Clinical practice report 2020, the global prevalence is projected to be 9.3% in 2019, and is expected to reach 10.2% by 2030 and 10.9% by 2045.

Obesity, a worldwide epidemic, has been on the rise in the last decade. Obesity results in degeneration of articular cartilage, leading to osteoarthritis. In 2016, 38% of adults were overweight, and 13% were obese. The increasing prevalence of diabetes and obesity is projected to increase the global non-alcoholic steatohepatitis (NASH) biomarker market growth. Another important driver is the growing awareness of NAFLD. However, the side-effects and risks associated with NASH therapeutics hinder the market growth.

The Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market report provides data tables and includes charts and graphs for visual analysis.

Market Segmentation

Market by Type
• Oxidative Stress Biomarker
• Serum Biomarker
• Hepatic Fibrosis Biomarker
• Apoptosis Biomarker
• Other Types

Market by End-User
• Diagnostic Lab
• Pharma & CRO Industry
• Hospital
• Academic Research Key

Report Highlights

- The report provides a detailed analysis of the current and future market trends, to identify the investment opportunities
- Market forecasts till 2028, using estimated market values as the base numbers
- Key market trends across the business segments, regions, and country
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities, and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2028

Companies Profiled

• MERCK & CO
• NOVARTIS AG
• NOVO NORDISK
• BRISTOL -MYERS SQUIBB COMPANY
• VIKING THERAPEUTICS
• ALLERGAN PLC (ACQUIRED BY ABBVIE)
• GENFIT SA
• ASTRAZENECA
• PFIZER INC
• SIEMENS HEALTHINEERS
• ZYDUS CADILA
• MADRIGAL PHARMACEUTICALS
• GILEAD SCIENCES INC

Related Reports

GLOBAL BARIATRIC SURGERY MARKET - Global bariatric surgery market is set to project a CAGR of 9.56% during 2019-2028.
https://inkwoodresearch.com/reports/bariatric-surgery-market/

GLOBAL HERNIA REPAIR DEVICES AND CONSUMABLES MARKET - Global hernia repair devices and consumables market is predicted to grow at a CAGR of 3.71% during 2021-2028.
https://inkwoodresearch.com/reports/hernia-repair-devices-and-consumables-market/

GLOBAL KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET - Global kidney cancer therapeutics and diagnostics market is anticipated to record a CAGR of 5.52% during 2019-2028.
https://inkwoodresearch.com/reports/kidney-cancer-therapeutics-and-diagnostics-market/

GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET - Global extra corporeal membrane oxygenation (ECMO) system market is estimated to project a CAGR of 4.74% during 2019-2028.
https://inkwoodresearch.com/reports/extra-corporeal-membrane-oxygenation-system-market/

Inkwood Research
169, Harrison Avenue
Boston, MA 02111
Tel: 1-(857)293-0150
Email: sales@inkwoodresearch.com
Website: www.inkwoodresearch.com

We at Inkwood research provide you with not just consulting services but also with syndicated and customized research reports which help advance your business further.

This release was published on openPR.